US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
イギリス
LSE
Teradata Del Dl 01 (0LEE) 銘柄情報

Teradata Del Dl 01 (0LEE)

38.49

0.00

(0.00%)

終了 6月16日 12:30AM

Teradata Del Dl 01 (0LEE) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

38.49

( - )

買値

38.49

売値

38.49

出来高

0.00

0.00 日の範囲 0.00

38.49 52 週間の範囲 38.49

時価総額

前日終値

38.49

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

US$ 2,125,917

発行済株式数

94,100,000

配当利回り

PER

7.54

1 株当たり利益 (EPS)

4.38

歳入

1.69B

純利益

421M

Teradata Corporation, together with its subsidiaries, provides an AI and knowledge platforms in the United States and internationally. It operates in two segments, Product Sales and Consulting Services. The company’s AI and Knowledge platform designed for enterprise-grade workloads. Its consulting s... Teradata Corporation, together with its subsidiaries, provides an AI and knowledge platforms in the United States and internationally. It operates in two segments, Product Sales and Consulting Services. The company’s AI and Knowledge platform designed for enterprise-grade workloads. Its consulting services include support services for organizations to establish data analytics and and AI vision, enable a hybrid ecosystem architecture, and identify and operationalize opportunities. The company serves clients in financial services, healthcare and life sciences, public sector, manufacturing, retail, telecommunications, and travel/transportation sectors through a direct sales force. Teradata Corporation was incorporated in 1979 and is headquartered in San Diego, California. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.teradata.com

本社

San Diego, United States

設立

1979

Teradata Del Dl 01 is listed in the sector of the ロンドン証券取引所 with ticker 0LEE. The last closing price for Teradata Del Dl 01 was US$38.49. Over the last year, Teradata Del Dl 01 shares have traded in a share price range of US$ 38.49 to US$ 38.49.

Teradata Del Dl 01 currently has 94,100,000 shares in issue. The market capitalisation of Teradata Del Dl 01 is US$3.62 billion. Teradata Del Dl 01 has a price to earnings ratio (PE ratio) of 7.54.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	38.49	38.49	38.49	1243	38.49	DE
52	0	0	38.49	38.49	38.49	948	38.49	DE
156	0	0	38.49	38.49	38.49	612	38.49	DE
260	0	0	38.49	38.49	38.49	624	38.49	DE

0LEE - Frequently Asked Questions (FAQ)

What is the current Teradata Del Dl 01 share price?

The current share price of Teradata Del Dl 01 is US$ 38.49

How many Teradata Del Dl 01 shares are in issue?

Teradata Del Dl 01 has 94,100,000 shares in issue

What is the market cap of Teradata Del Dl 01?

The market capitalisation of Teradata Del Dl 01 is USD 3.62B

What is the 1 year trading range for Teradata Del Dl 01 share price?

Teradata Del Dl 01 has traded in the range of US$ 38.49 to US$ 38.49 during the past year

What is the PE ratio of Teradata Del Dl 01?

The price to earnings ratio of Teradata Del Dl 01 is 7.54

What is the cash to sales ratio of Teradata Del Dl 01?

The cash to sales ratio of Teradata Del Dl 01 is 1.84

What is the registered address of Teradata Del Dl 01?

The registered address for Teradata Del Dl 01 is 17095 Via Del Campo, San Diego, California, 92127

What is the Teradata Del Dl 01 website address?

The website address for Teradata Del Dl 01 is www.teradata.com

Mdk1

Why this paper is highly interesting for Lightwave Logic (GROK)
This is a top-scored paper that strongly validates Lightwave Logic’s Perkinamine™ chromophore series 3 as a leading electro-optic material for next-generation datacenter optics.

Key Reasons Why It Matters:

janice shell

janice shell 12分前

Now that's a real head-scratcher! But shorts have to be smart, so I'd say torso and head.

gitreal

gitreal 14分前

Anyone with half a Brian can see this company is being crazy shorted!

Which half? Torso and head?

HyGro

NWBO could file an FDA application anytime but they haven't and have shown no intent to do so. Instead they are just burning more shareholder cash and if approved, will lose money on every dose because NICE will hammer the reimbursement down below Advent's costs. NWBO will lose money and collaps

US Market News

US Market News 20分前

TotalEnergies SE: Disclosure of Transactions in Own SharesJune 16, 2026 2:00 AM
Business Wire Regulatory News In accordance with the authorizations given by the shareholders’ general meeting on May 29, 2026, to trade on its shares and pursuant to applicable law on share

HyGro

Sorry, not enough. NWBO won't make any profit selling in the UK. NICE hates personalized oncology treatments and won't pay enough for NWBO to make a profit.
That's what counts. And NWBO will go under or just become Advent Contract Manufacturer. They have no cash or credit to fund any sub

biotechinvestor1

biotechinvestor1 24分前

Don’t start spazzing again, Alteogen circus clown. The Sanofi news is old.
Once Merck settles/licenses from Halozyme, Sanofi and all others will follow.
Your Alteogen stole IP from Halozyme and will pay a price for it. You can count on it.
The companies who have signed with Alte

Steady_T

Steady_T 24分前

Your theory will be put to the test after UK approval. I give it 6 months as a guess.

HyGro

What's true is NWBO won't file with the FDA for approval in the U.S. Hasn't done it for years when it could have done it. They know FDA won't accept their P3 trial. How many years are you going to wait to find out???

HyGro

What's True is NWBO won't file with the FDA for approval in the U.S. Hasn't done it for years when it could have done it. They know FDA won't accept their P3 trial. How long are you going to wait to find out???

Mdk1

Google Scholar alert - new article: "A Comparison of Plasmonic Modulator Structures in the O- and C-Band for the 400G/Lane IM/DD Era"
>>> " In ALL cases, the same electro-optic organic material, Lightwave Logic’s PerkinamineTM
chromophore series 3, was used " !
https://ieeexplor

CelestialSage6

CelestialSage6 32分前

Stop talking nonsense. Sanofi is conducting clinical trials using Alteogen's technology; what are your thoughts on this? Did you sense a crisis for Halozyme?

biotechinvestor1

biotechinvestor1 34分前

I love it when Alteogen fanboys post on this board. Nearly every time they show up, Halozyme has a run up.

DR_rugby

DR_rugby 35分前

Prophecy is coming

https://www.cnbc.com/2026/06/16/boj-rate-hike-historic-inflation.html

Japanese rates are going higher

Yen is yet to be stabilize

The great unwinding is coming soon

GLTA

BigBadWolf

BigBadWolf 42分前

Authorized Shares 1,800,000,000 06/15/2026
Outstanding Shares 1,619,034,363 06/15/2026 >5m
Restricted 480,530,670 06/15/2026 >5m
Unrestricted 1,138,503,693 06/15/2026
Held at DTC 1,011,499,104 06/15/2026 >8m

Authorized Shares 1,800,000,000 06/05/2026

4retire

4retire 45分前

One has to question why a “cash rich” company would need to raise $20-25 billion by going to bond sales that will be in 7 tranches, ranging from 2 to 30 years. The statement is that it’s for general purposes and to redo some current debt financing.

Based on recent financials, NVDA’

tank777

tank777 45分前

FACT CHECK:

The key distinction is between “eligible” and “selected.”

To date, CMS has not publicly released a list of approved CBD brands for the Substance Access Beneficiary Engagement Incentive (BEI) program.

That means:

Mr. Tate

Mr. Tate 45分前

Your Mother should've named you loser0. Awww did someone take your lunch money in school loser0? IMO

jhdf51

jhdf51 46分前

Great.. thank you.

ducci1

ducci1 47分前

Pivot Calcs: SPX Pivot 7549---R1 7582---S1 7521---SPY Pivot 754---R1 757---S1 752----ES Pivot 7601---R1 7667---S1 7555----VIX Pivot 16.35---R1 16.70---S1 15.85---15 min Bull/Bear R/Line 18.34!----!!LOL!!

Mr. Tate

Mr. Tate 47分前

Are you for real loser0? You always hide behind a computer screen loser0? IMO

Wolf-man jack

Wolf-man jack 52分前

WQLF SAYS: .Charlottes Web products Have Not been PUBLICLY STATED as being OFFICIALLY APPROVED. In the case of CV SCIENCES, the CMS Pilot Program still has time to Announce CV SCIENCES or are they already enrolled? Cornbread was never announced, so one can not reliably state that it is A True FACT Y

knrorrel

knrorrel 1時間前

Wow, that would be fantastic. It would be a dream come true for me after the many losses (FORW, BLEG, PAVS) this year... I have to admit, the latest news was fantastic; the company shouldn't be trading at this level and could soon see a massive surge—similar to how QBTS went from $0.50 to $20 years

knrorrel

knrorrel 1時間前

$GPUS GPUS should make a magnificent, big, and sustained climb now; we just need a little patience, the ability to weather the fluctuations (ups and downs), and steady nerves. Ultimately, however, we should be trading in the multi-dollar range., all only imho

many great news &

Teradata Del Dl 01

Intesa Sanpaolo

Ci Us Stock Selection Co...

Boardwalktech Software (QB)

Tikehau Capital

Antimatter.Finance Governance To

Saltaire Fin 35

Natural Beauty Bio Techn... (PK)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。